GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Dishman Carbogen Amics Ltd (NSE:DCAL) » Definitions » Equity-to-Asset

Dishman Carbogen Amics (NSE:DCAL) Equity-to-Asset : 0.56 (As of Sep. 2024)


View and export this data going back to 2004. Start your Free Trial

What is Dishman Carbogen Amics Equity-to-Asset?

Equity to Asset ratio is calculated as total stockholders equity divided by total asset. Dishman Carbogen Amics's Total Stockholders Equity for the quarter that ended in Sep. 2024 was ₹57,368 Mil. Dishman Carbogen Amics's Total Assets for the quarter that ended in Sep. 2024 was ₹101,805 Mil. Therefore, Dishman Carbogen Amics's Equity to Asset Ratio for the quarter that ended in Sep. 2024 was 0.56.

The historical rank and industry rank for Dishman Carbogen Amics's Equity-to-Asset or its related term are showing as below:

NSE:DCAL' s Equity-to-Asset Range Over the Past 10 Years
Min: 0.44   Med: 0.66   Max: 0.73
Current: 0.56

During the past 13 years, the highest Equity to Asset Ratio of Dishman Carbogen Amics was 0.73. The lowest was 0.44. And the median was 0.66.

NSE:DCAL's Equity-to-Asset is ranked worse than
59.79% of 1512 companies
in the Biotechnology industry
Industry Median: 0.67 vs NSE:DCAL: 0.56

Dishman Carbogen Amics Equity-to-Asset Historical Data

The historical data trend for Dishman Carbogen Amics's Equity-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Dishman Carbogen Amics Equity-to-Asset Chart

Dishman Carbogen Amics Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Equity-to-Asset
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.70 0.68 0.64 0.62 0.59

Dishman Carbogen Amics Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Equity-to-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.61 - 0.59 - 0.56

Competitive Comparison of Dishman Carbogen Amics's Equity-to-Asset

For the Biotechnology subindustry, Dishman Carbogen Amics's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Dishman Carbogen Amics's Equity-to-Asset Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Dishman Carbogen Amics's Equity-to-Asset distribution charts can be found below:

* The bar in red indicates where Dishman Carbogen Amics's Equity-to-Asset falls into.



Dishman Carbogen Amics Equity-to-Asset Calculation

Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.

Dishman Carbogen Amics's Equity to Asset Ratio for the fiscal year that ended in Mar. 2024 is calculated as

Equity to Asset (A: Mar. 2024 )=Total Stockholders Equity/Total Assets
=56275/95814.1
=0.59

Dishman Carbogen Amics's Equity to Asset Ratio for the quarter that ended in Sep. 2024 is calculated as

Equity to Asset (Q: Sep. 2024 )=Total Stockholders Equity/Total Assets
=57367.6/101804.5
=0.56

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Dishman Carbogen Amics  (NSE:DCAL) Equity-to-Asset Explanation

Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.

For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.


Dishman Carbogen Amics Equity-to-Asset Related Terms

Thank you for viewing the detailed overview of Dishman Carbogen Amics's Equity-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


Dishman Carbogen Amics Business Description

Traded in Other Exchanges
Address
Iscon-Bopal Road, Dishman Corporate House, Ambli, Ahmedabad, GJ, IND, 380 058
Dishman Carbogen Amics Ltd is a biotechnology company that provides contract research and manufacturing services for pharmaceutical companies. It manufactures bulk drugs, specialty chemicals, and outsourced goods. Additionally, the company produces vitamins, such as vitamin D2 and vitamin D3, reagents, antiseptics and disinfectants, transfer catalysts, personal-care ingredients, pharma intermediates, and ammonium and phosphonium high-purity solid Quats. The business generates the vast majority of its revenue in India.

Dishman Carbogen Amics Headlines

No Headlines